Health Canada is building up its capacity in anticipation of an increase in the number of biosimilar evaluations it will be carrying out over the coming months and years. At the same time, the department is boosting its educational and outreach efforts in order to build confidence in biosimilar medicines.
Health Canada is also in the midst of evaluating the responses to a consultation earlier this year on the best...






